SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-009183
Filing Date
2023-08-22
Accepted
2023-08-22 13:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27658
2 filename2.txt TEXT-EXTRACT 1503
  Complete submission text file 0000000000-23-009183.txt   40297
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filed for) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations